Human Factor H (FH) Impairs Protective Meningococcal Anti-FHbp Antibody Responses and the Antibodies Enhance FH Binding

por Costa, Isabella, Pajon, Rolando, Granoff, Dan M.
Publicado 2014

Comparing the Similarity of Different Groups of Bacteria to the Human Proteome

por Trost, Brett, Pajon, Rolando, Jayaprakash, Teenus, Kusalik, Anthony
Publicado 2012

Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa

por Pajon, Rolando, Fergus, Andrew M., Granoff, Dan M.
Publicado 2013

A Mutant Library Approach to Identify Improved Meningococcal Factor H Binding Protein Vaccine Antigens

por Konar, Monica, Rossi, Raffaella, Walter, Helen, Pajon, Rolando, Beernink, Peter T.
Publicado 2015

A Broadly Cross-Reactive Monoclonal Antibody Against an Epitope on the N-terminus of Meningococcal fHbp

por Vu, David M., Pajon, Rolando, Reason, Donald C., Granoff, Dan M.
Publicado 2012

ERRATUM: A Broadly Cross-Reactive Monoclonal Antibody Against an Epitope on the N-terminus of Meningococcal fHbp

por Vu, David M., Pajon, Rolando, Reason, Donald C., Granoff, Dan M.
Publicado 2013

Meningococcal Factor H Binding Proteins in Epidemic Strains from Africa: Implications for Vaccine Development

por Pajon, Rolando, Fergus, Andrew M., Koeberling, Oliver, Caugant, Dominique A., Granoff, Dan M.
Publicado 2011

The Effect of Human Factor H on Immunogenicity of Meningococcal Native Outer Membrane Vesicle Vaccines with Over-Expressed Factor H Binding Protein

por Beernink, Peter T., Shaughnessy, Jutamas, Pajon, Rolando, Braga, Emily M., Ram, Sanjay, Granoff, Dan M.
Publicado 2012

A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine

por Chu, Laurence, McPhee, Roderick, Huang, Wenmei, Bennett, Hamilton, Pajon, Rolando, Nestorova, Biliana, Leav, Brett
Publicado 2021

Clinical utility of Elecsys Anti-SARS-CoV-2 S assay in COVID-19 vaccination: An exploratory analysis of the mRNA-1273 phase 1 trial

por Jochum, Simon, Kirste, Imke, Hortsch, Sayuri, Grunert, Veit Peter, Legault, Holly, Eichenlaub, Udo, Kashlan, Basel, Pajon, Rolando
Publicado 2021

Clinical Utility of Elecsys Anti-SARS-CoV-2 S Assay in COVID-19 Vaccination: An Exploratory Analysis of the mRNA-1273 Phase 1 Trial

por Jochum, Simon, Kirste, Imke, Hortsch, Sayuri, Grunert, Veit Peter, Legault, Holly, Eichenlaub, Udo, Kashlan, Basel, Pajon, Rolando
Publicado 2022

Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351

por Shen, Xiaoying, Tang, Haili, Pajon, Rolando, Smith, Gale, Glenn, Gregory M., Shi, Wei, Korber, Bette, Montefiori, David C.
Publicado 2021

Quantifying the Vaccine-Induced Humoral Immune Response to Spike-Receptor Binding Domain as a Surrogate for Neutralization Testing Following mRNA-1273 (Spikevax) Vaccination Agains...

por Kirste, Imke, Hortsch, Sayuri, Grunert, Veit Peter, Legault, Holly, Maglinao, Maha, Eichenlaub, Udo, Kashlan, Basel, Pajon, Rolando, Jochum, Simon
Publicado 2022

mRNA-1273 Vaccine-elicited Neutralization of SARS-CoV-2 Omicron in Adolescents and Children

por Girard, Bethany, Tomassini, Joanne E, Deng, Weiping, Maglinao, Maha, Zhou, Honghong, Figueroa, Amparo, Ghamloush, Sabine Schnyder, Montefiori, David C, Das, Rituparna, Pajon, Rolando
Publicado 2022

Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants

por Choi, Angela, Koch, Matthew, Wu, Kai, Dixon, Groves, Oestreicher, Judy, Legault, Holly, Stewart-Jones, Guillaume B. E., Colpitts, Tonya, Pajon, Rolando, Bennett, Hamilton, Carfi, Andrea, Edwards, Darin K.
Publicado 2021

Safety and Immunogenicity of a 100 μg mRNA-1273 Vaccine Booster for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)

por Chalkias, Spyros, Schwartz, Howard, Nestorova, Biliana, Feng, Jing, Chang, Ying, Zhou, Honghong, Dutko, Frank J., Edwards, Darin K., Montefiori, David, Pajon, Rolando, Leav, Brett, Miller, Jacqueline M., Das, Rituparna
Publicado 2022

Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents

por Ali, Kashif, Berman, Gary, Zhou, Honghong, Deng, Weiping, Faughnan, Veronica, Coronado-Voges, Maria, Ding, Baoyu, Dooley, Jacqueline, Girard, Bethany, Hillebrand, William, Pajon, Rolando, Miller, Jacqueline M., Leav, Brett, McPhee, Roderick
Publicado 2021

A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus

por August, Allison, Attarwala, Husain Z., Himansu, Sunny, Kalidindi, Shiva, Lu, Sophia, Pajon, Rolando, Han, Shu, Lecerf, Jean-Michel, Tomassini, Joanne E., Hard, Marjie, Ptaszek, Leon M., Crowe, James E., Zaks, Tal
Publicado 2021

Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus

por August, Allison, Attarwala, Husain Z., Himansu, Sunny, Kalidindi, Shiva, Lu, Sophia, Pajon, Rolando, Han, Shu, Lecerf, Jean-Michel, Tomassini, Joanne E., Hard, Marjie, Ptaszek, Leon M., Crowe, James E., Zaks, Tal
Publicado 2022

Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial

por Chu, Laurence, Vrbicky, Keith, Montefiori, David, Huang, Wenmei, Nestorova, Biliana, Chang, Ying, Carfi, Andrea, Edwards, Darin K., Oestreicher, Judy, Legault, Holly, Dutko, Frank J., Girard, Bethany, Pajon, Rolando, Miller, Jacqueline M., Das, Rituparna, Leav, Brett, McPhee, Roderick
Publicado 2022